Advancements in Glioma Care: Focus on Emerging Neurosurgical Techniques
Overview
Affiliations
Background: Despite significant advances in understanding the molecular pathways of glioma, translating this knowledge into effective long-term solutions remains a challenge. Indeed, gliomas pose a significant challenge to neurosurgical oncology because of their diverse histopathological features, genetic heterogeneity, and clinical manifestations. Relevant sections: This study focuses on glioma complexity by reviewing recent advances in their management, also considering new classification systems and emerging neurosurgical techniques. To bridge the gap between new neurosurgical approaches and standards of care, the importance of molecular diagnosis and the use of techniques such as laser interstitial thermal therapy (LITT) and focused ultrasound (FUS) are emphasized, exploring how the integration of molecular knowledge with emerging neurosurgical approaches can personalize and improve the treatment of gliomas.
Conclusions: The choice between LITT and FUS should be tailored to each case, considering factors such as tumor characteristics and patient health. LITT is favored for larger, complex tumors, while FUS is standard for smaller, deep-seated ones. Both techniques are equally effective for small and superficial tumors. Our study provides clear guidance for treating pediatric low-grade gliomas and highlights the crucial roles of LITT and FUS in managing high-grade gliomas in adults. This research sets the stage for improved patient care and future developments in the field of neurosurgery.
De Simone M, Choucha A, Ranalli C, Pecoraro G, Appay R, Chinot O Neurosurg Rev. 2025; 48(1):271.
PMID: 40014162 PMC: 11868189. DOI: 10.1007/s10143-025-03436-x.
GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches.
Yang Y, Li W, Zhao Y, Sun M, Xing F, Yang J Biomedicines. 2025; 13(2).
PMID: 40002794 PMC: 11852679. DOI: 10.3390/biomedicines13020382.
Advanced External Beam Stereotactic Radiotherapy for Skull Base Reirradiation.
Wang H, Alsanea F, Rhee D, Zhang X, Liu W, Yang J Cancers (Basel). 2025; 17(3).
PMID: 39941906 PMC: 11817895. DOI: 10.3390/cancers17030540.
Song D, Fan G, Chang M Cancers (Basel). 2025; 17(1.
PMID: 39796702 PMC: 11719598. DOI: 10.3390/cancers17010074.
"Beyond the Knife"-Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology.
Guru S, Lam F, Akhavan-Sigari A, Hori Y, AbuReesh D, Tayag A Brain Sci. 2025; 14(12.
PMID: 39766452 PMC: 11674837. DOI: 10.3390/brainsci14121253.